Accurate imaging sits at the center of every successful venous intervention, and IVUS venous stenting has become a standard part of how interventionalists plan and confirm stent placement in the iliofemoral venous system. Unlike standard venography, which only outlines the vessel from the outside, intravascular ultrasound generates a cross-sectional view from within the vein itself. This distinction matters because many venous obstructions, particularly those caused by chronic compression or old scar tissue, can be underestimated or entirely missed on a two-dimensional contrast image. For patients being evaluated for iliofemoral obstruction or post-thrombotic changes, understanding how this imaging technology is used can clarify why physicians often request it before deciding on a treatment plan.
What Does IVUS Add That Venography Cannot Show?
Conventional venography relies on contrast flow patterns to infer where a vein is narrowed. Intravascular ultrasound instead threads a small imaging catheter through the vein, producing real-time cross-sectional images of the vessel wall, lumen diameter, and any web-like scar bands that often develop after a prior clot. Because venous walls are thin and can collapse or compress asymmently, a flat contrast image sometimes fails to reveal the true severity of a stenosis. IVUS venous stenting workflows use this internal view to measure the vessel more precisely, identify the transition zone between healthy and diseased segments, and confirm that a lesion is significant enough to warrant treatment.
How Does Imaging Guide Stent Sizing and Landing Zones?
One of the more practical roles of intravascular ultrasound is helping the treating physician select an appropriately sized stent and determine where it should begin and end. Venous stents that are undersized or placed short of the diseased segment are more likely to be associated with suboptimal outcomes, while imaging-confirmed measurements help reduce this risk. During the procedure, the physician typically pulls the imaging catheter back through the vein to map the full length of the obstruction, noting minimum lumen areas and any residual compression points. This mapping directly informs decisions about stent length, diameter, and the exact landing zones needed to fully cover the diseased segment without leaving gaps.
Why Does Stent Apposition Matter After Deployment?
Stent apposition refers to how completely the metal scaffold contacts the vessel wall once it has been deployed. Incomplete apposition can leave small gaps between the stent struts and the vein wall, which may be associated with turbulent flow patterns or a higher chance of the stent narrowing over time. Intravascular ultrasound allows the physician to inspect apposition immediately after placement, rather than relying on an external contrast image that cannot show wall-to-strut contact in detail. If any portion of the stent is not fully expanded against the vessel wall, additional balloon inflation can often be performed during the same procedure to help improve contact.
Where Does This Imaging Fit Within the Broader Procedure?
Intravascular ultrasound is typically used at several points during a venous stenting procedure: before treatment to characterize the lesion, during the procedure to confirm sizing, and after deployment to check the result. It is generally used alongside venography rather than replacing it entirely, since each modality offers different information. Patients considering treatment for iliofemoral venous obstruction can review general information about self-expanding venous stent options on the INVAMED venous stents category page, which outlines device types used in this area of practice.
Can imaging findings change the treatment plan mid-procedure?
Yes, intravascular ultrasound findings can lead a physician to adjust stent length, diameter, or landing zone selection compared to what was initially planned from venography alone. This is one of the reasons the technology is used at multiple points during the intervention rather than only at the outset. Any changes to the treatment plan remain at the discretion of the treating physician based on real-time findings.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.